Stockscreener 앱 받기
0.82
6.82%
-0.06
시간 외 거래:
.83
0.01
+1.22%
전일 마감가:
$0.88
열려 있는:
$0.88
하루 거래량:
93,787
Relative Volume:
1.02
시가총액:
$2.39M
수익:
$4.51M
순이익/손실:
$-7.66M
주가수익비율:
-0.217
EPS:
-3.778
순현금흐름:
$-7.51M
1주 성능:
+2.50%
1개월 성능:
-4.65%
6개월 성능:
-64.19%
1년 성능:
-70.50%
1일 변동 폭
$0.82
$0.8999
1주일 범위
$0.7624
$0.926
52주 변동 폭
$0.7321
$7.98
Inmed Pharmaceuticals Inc Stock (INM) Company Profile
명칭
Inmed Pharmaceuticals Inc
전화
(604) 669-7207
주소
1445-885 WEST GEORGIA ST., VANCOUVER
Compare INM vs TAK, ZTS, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INM
Inmed Pharmaceuticals Inc
|
0.82 | 2.57M | 4.51M | -7.66M | -7.51M | -3.778 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.11 | 56.96B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
115.99 | 49.54B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.23 | 45.90B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.44 | 34.48B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
527.00 | 23.24B | 3.18B | 1.33B | 1.04B | 27.90 |
Inmed Pharmaceuticals Inc 주식(INM)의 최신 뉴스
Aug Weekly: Can InMed Pharmaceuticals Inc be the next market leaderBear Alert & Accurate Entry/Exit Alerts - baoquankhu1.vn
Ideas Watch: Can InMed Pharmaceuticals Inc be the next market leader2026 Institutional Moves & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Published on: 2026-03-17 19:00:00 - baoquankhu1.vn
CEO Moves: Will InMed Pharmaceuticals Inc stock go up in YEAR2026 Review & AI Enhanced Execution Alerts - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's After-Market Session - Sahm
InMed Pharmaceuticals Advances INM-901 for Alzheimer’s and INM-089 for Macular Degeneration with FDA Engagement Planned for 2026-2027 1 - Minichart
InMed Pharmaceuticals (INM) Sets 2026 Development Goals - GuruFocus
InMed Provides Update on Pharmaceutical Development ProgramsAdvancing Lead Drug Candidates Towards IND and Clinical Trial - Investing News Network
InMed outlines 2026 development plans for lead programs - TipRanks
InMed Provides 2026 Development Outlook; Targets FDA pre-IND for INM-901 and Phase 1 in 2027 - TradingView
InMed (INM) sets 2026 goals for Alzheimer’s and eye-disease drug programs - Stock Titan
InMed's 2026 push to bring Alzheimer's, eye drug candidates to human testing - Stock Titan
Can InMed Pharmaceuticals Inc reach all time highs this yearJuly 2025 Technicals & Weekly Momentum Picks - baoquankhu1.vn
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline - Investing News Network
According to the latest filing disclosed by the U.S. Securities and Exchange Commission (SEC), InMed Pharmaceuticals Inc (INM) officially confirmed and passed a resolution on March 4 to gradually terminate the commercial operations of its Baymedica divisio - Bitget
InMed Pharmaceuticals Exits BayMedica to Refocus on Pipeline - TipRanks
InMed Pharmaceuticals IncOn March 4, Co Confirmed And Approved The Decision To Wind Down Baymedica's Commercial OperationsSEC Filing - TradingView
InMed (NASDAQ: INM) winds down BayMedica unit and pivots fully to drug development - Stock Titan
U.S. law threat pushes InMed to shut BayMedica unit, pivot to Alzheimer's drugs - Stock Titan
INM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Can InMed Pharmaceuticals Inc. reach all time highs this yearQuarterly Performance Summary & Technical Confirmation Trade Alerts - mfd.ru
Risk Off: Can InMed Pharmaceuticals Inc be the next market leaderMarket Trend Report & Daily Volume Surge Signals - baoquankhu1.vn
INM Should I Buy - Intellectia AI
Published on: 2026-02-27 15:19:59 - baoquankhu1.vn
Is InMed Pharmaceuticals Inc. undervalued by DCF analysis2025 Bull vs Bear & Safe Capital Growth Stock Tips - mfd.ru
Is InMed Pharmaceuticals Inc. (MWG) stock a contrarian opportunity2025 Market Outlook & Safe Entry Momentum Tips - mfd.ru
INM Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Aug Movers: Is InMed Pharmaceuticals Inc undervalued by DCF analysisMarket Weekly Review & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
InMed Highlights Q2 Results Amid Cash, Regulatory Pressures - TipRanks
InMed Pharmaceuticals Inc Reports Q2 2026 Financial Results and Business Update - TradingView
InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update - Investing News Network
InMed Pharmaceuticals Inc. SEC 10-Q Report - TradingView
What analysts say about InMed Pharmaceuticals Inc. stockJuly 2025 Fed Impact & Verified Stock Trade Ideas - mfd.ru
What drives InMed Pharmaceuticals Inc.’s stock priceGlobal Markets & Verified Entry Point Detection - mfd.ru
Will InMed Pharmaceuticals Inc stock go up in YEAR2025 Key Highlights & Safe Entry Zone Identification - baoquankhu1.vn
Nasdaq Moves: What analysts say about InMed Pharmaceuticals Inc stockTrend Reversal & Growth Focused Investment Plans - baoquankhu1.vn
Can InMed Pharmaceuticals Inc. stock double in the next yearJuly 2025 Fed Impact & Weekly High Conviction Trade Ideas - mfd.ru
Aug Summary: Will InMed Pharmaceuticals Inc. stock go up in YEARJuly 2025 Selloffs & Weekly Chart Analysis and Guides - mfd.ru
Should I add InMed Pharmaceuticals Inc. stock to my portfolio2025 Geopolitical Influence & Weekly High Return Stock Opportunities - mfd.ru
Risk Analysis: What drives InMed Pharmaceuticals Incs stock price2025 Support & Resistance & Momentum Based Trading Ideas - baoquankhu1.vn
InMed faces challenges from new US legislation - MSN
Chart Watch: What analysts say about InMed Pharmaceuticals Inc stockWeekly Trading Summary & Precise Buy Zone Identification - baoquankhu1.vn
Market Catalysts: What analysts say about InMed Pharmaceuticals Inc stockBull Run & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Aug PostEarnings: Does Nano X Imaging Ltd align with a passive investing strategy - baoquankhu1.vn
Performance Recap: Is InMed Pharmaceuticals Inc undervalued by DCF analysisWeekly Profit Analysis & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Breakout Zone: Can InMed Pharmaceuticals Inc stock surprise with earnings upsideJuly 2025 Big Picture & Safe Capital Investment Plans - Bộ Nội Vụ
Returns Recap: Can InMed Pharmaceuticals Inc. stock beat analyst upgrades2025 Technical Overview & Consistent Profit Alerts - Улправда
Will InMed Pharmaceuticals Inc. (MWG) stock beat revenue estimates2025 Year in Review & Growth Focused Entry Reports - Улправда
Pullback Watch: Can InMed Pharmaceuticals Inc. stock beat analyst upgradesOptions Play & Weekly Watchlist for Hot Stocks - Улправда
What dividend safety score for InMed Pharmaceuticals Inc. stockQuarterly Earnings Review & Budget Friendly Portfolio - Улправда
InMed Pharmaceuticals (NASDAQ:INM) Trading Up 5% – Time to Buy? - Defense World
Inmed Pharmaceuticals Inc (INM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.02%
0.77%
자본화:
|
볼륨(24시간):